Plassche Douglas bought ELTP

January 9, 2026 · Form 4 insider transaction

Plassche Douglas bought 2,500,000 shares of Elite Pharmaceuticals, Inc. at $0.03 per share, a transaction worth $75.0K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.